Jacob Thaysen - Agilent Technologies President

A -- USA Stock  

USD 77.90  0.75  0.97%

  President
Mr. Jacob Thaysen serves as Senior Vice President, President, Life Sciences and Applied Markets Group of the Company. He has served as Senior Vice President, Agilent and President, Life Sciences and Applied Markets Group, since April 2018. From November 2014 to April 2018 he served as Senior Vice President, Agilent and President, Diagnostics and Genomics Group. From October 2013 to November 2014 he served as Vice President and General Manager of the Diagnostics and Genomics business. Prior to that he served as Vice President and General Manager of the Genomics Solutions unit from January 2013 to October 2013. Before joining Agilent, he served in various capacities at Dako AS, a Danish diagnostics company, including as Corporationrationrate Vice President of RD, Vice President, System Development, RD, Vice President, Strategic Marketing and Vice President, Global Sales Operations. Prior to Dako, Mr. Thaysen worked as a management consultant and Chief Technical Officer and founder of a hightech startup company.
Age: 42  President Since 2018      
408-345-8886  http://www.agilent.com

Management Efficiency

The company has return on total asset of 7.45 % which means that for every 100 dollars spent on asset it generated profit of $7.45. This is acceptable considering the industry classification. Similarly, it shows return on equity (ROE) of 23.02 % implying that it made 23.02 on every $100 invested by shareholders.
The company has accumulated 1.8B in total debt with debt to equity ratio (D/E) of 37.8 implying that the company may be unable to produce cash to meet its debt commitments. Agilent Technologies has Current Ratio of 2.09 implying that it is liquid and has the capability to pay out its interest payments when they become due.

Similar Executives

Showing few of many executives

PRESIDENT Since

Heather AceDexCom
2016
William SmithFluidigm Corporation
2012
Samuel EbertsLaboratory Corporation of Ameri
2009
John ListerDexCom
2015
William KlitgaardLaboratory Corporation of Ameri
2015
Peter WilkinsonLaboratory Corporation of Ameri
2019
Yasushi NagasakiEmmaus Life Sciences
2019
Lisa UthgenanntLaboratory Corporation of Ameri
2015
Andrew BaloDexCom
2016
Syed KamalAmerican Renal Associates Holdi
N/A
Brian CaveneyLaboratory Corporation of Ameri
2017
Glenn EisenbergLaboratory Corporation of Ameri
2014
Patrick MurphyDexCom
2018
Scott FrommerLaboratory Corporation of Ameri
2016
Bradley KregerFluidigm Corporation
2018
John McDonoughAmerican Renal Associates Holdi
2015
Donald AbbeyDexCom
2017
Don WilliamsonAmerican Renal Associates Holdi
2017
Jake LeachDexCom
2018
Ana HookerExact Sciences Corporation
2015
Scott JohnsonExact Sciences Corporation
2017

Entity Summary

Agilent Technologies, Inc. provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The company was founded in 1999 and is headquartered in Santa Clara, California. Agilent Technologies operates under Diagnostics Research classification in USA and is traded on BATS Exchange. It employs 15700 people.Agilent Technologies (A) is traded on BATS Exchange in USA. It is located in 5301 Stevens Creek Boulevard and employs 15,700 people. Agilent Technologies is listed under Measuring and Control Equipment category by Fama And French industry classification.

Agilent Technologies Leadership Team

Daniel Podolsky, Independent Director
Hans Bishop, Independent Director
George Scangos, Independent Director
Sue Rataj, Independent Director
Jacob Thaysen, Senior Vice President, President, Life Sciences and Applied Markets Group
Samraat Raha, Senior Vice President, President, Diagnostics and Genomics Group
Mark Doak, Senior Vice President, President - Agilent CrossLab Group
Paul Clark, Independent Director
Mala Anand, Independent Director
Robert McMahon, Chief Financial Officer, Senior Vice President
Ankur Dhingra, Investor Relations
Hajime Tada, Interim General Counsel
James Cullen, Independent Non-Executive Chairman of the Board
Michael McMullen, CEO and President Director and Member of Executive Committee
Patrick Kaltenbach, Sr. VP and President of Life Sciences and Applied Markets Group (LSAG) Bus. Unit
Rodney Gonsalves, Chief Accounting Officer, Vice President, Corporate Controllership
Henrik AncherJensen, Senior Vice President and Presidentident - Order Fulfillment
Dow Wilson, Independent Director
Heidi Kunz, Independent Director
Dominique Grau, Senior Vice President - Human Resources
Heidi Fields, Independent Director
Michael Tang, Senior Vice President General Counsel, Secretary
Alicia Rodriguez, Vice President - Investor Relations
Tadataka Yamada, Independent Director
Didier Hirsch, CFO and Sr. VP
Boon Koh, Independent Chairman of the Board
Robert Herbold, Independent Director

Stock Performance Indicators

Current Sentiment - A

Agilent Technologies Investor Sentiment

Most of Macroaxis users are presently bullish on Agilent Technologies. What is your sentiment towards investing in Agilent Technologies? Are you bullish or bearish?
Bullish
Bearish
98% Bullish
2% Bearish
Skip

Agilent Technologies Pair Correlation

Equities Pair Trading Analysis

Correlation analysis and pair trading evaluation for Agilent Technologies and Guardant Health. Pair trading can be used as a hedging technique within a particular sector or industry or even over random equities to generate better risk-adjusted return
Run Pair Correlation  
Check also Trending Equities. Please also try Idea Analyzer module to analyze all characteristics, volatility and risk-adjusted return of macroaxis ideas.
Search macroaxis.com